Targeting New Functions and Applications of Bacterial Two‐component Systems DOI
Shixia Ji, Conggang Li, Maili Liu

и другие.

ChemBioChem, Год журнала: 2024, Номер unknown

Опубликована: Авг. 23, 2024

Two-component signal transduction systems (TCSs) are regulatory widely distributed in eubacteria, archaea, and a few eukaryotic organisms, but not mammalian cells. A typical TCS consists of histidine kinase response regulator protein. Functional mechanistic studies on different TCSs have greatly advanced the understanding cellular phosphotransfer mechanisms. In this concept paper, we focus His-Asp mechanism, ATP synthesis function, antimicrobial drug design, biosensors protein allostery mechanisms based recent investigations to inspire new applications future research perspectives.

Язык: Английский

Deciphering the role of mitochondria in human fungal drug resistance DOI Creative Commons
Yuanyuan Ma, Yachun Zhou,

Tianyuan Jia

и другие.

Mycology&#58 An International Journal on Fungal Biology, Год журнала: 2025, Номер unknown, С. 1 - 14

Опубликована: Март 10, 2025

Язык: Английский

Процитировано

1

Metabolic regulation of the host–fungus interaction: from biological principles to therapeutic opportunities DOI Creative Commons
Rita Silva-Gomes, Inês Caldeira, Raquel Fernandes

и другие.

Journal of Leukocyte Biology, Год журнала: 2024, Номер 116(3), С. 469 - 486

Опубликована: Март 18, 2024

Abstract Fungal infections present a significant global public health concern, impacting over 1 billion individuals worldwide and resulting in more than 3 million deaths annually. Despite considerable progress recent years, the management of fungal remains challenging. The limited development novel diagnostic therapeutic approaches is largely attributed to our incomplete understanding pathogenetic mechanisms involved these diseases. Recent research has highlighted pivotal role cellular metabolism regulating interaction between fungi their hosts. In response infection, immune cells undergo complex metabolic adjustments meet energy demands necessary for an effective response. A comprehensive circuits governing antifungal immunity, combined with integration individual host traits, holds potential inform medical interventions infections. This review explores insights into immunometabolic regulation host–fungal interactions infection outcome discusses how repurposing cell function could be exploited innovative personalized approaches.

Язык: Английский

Процитировано

5

Alternative Oxidase – Aid or obstacle to combat the rise of fungal pathogens? DOI Creative Commons
Elizabeth Edrich, Lucian Duvenage, Campbell W. Gourlay

и другие.

Biochimica et Biophysica Acta (BBA) - Bioenergetics, Год журнала: 2024, Номер 1865(2), С. 149031 - 149031

Опубликована: Янв. 7, 2024

Fungal pathogens present a growing threat to both humans and global health security alike. Increasing evidence of antifungal resistance in fungal populations that infect plant species has increased reliance on combination therapies shown the need for new therapeutic targets be investigated. Here, we review roles mitochondria respiration pathogenesis discuss role Alternative Oxidase enzyme (Aox) human phytopathogens. exists Aox within mechanisms underpin virulence. also plays important adaptability may prove useful dual targeted fungal-specific approaches. As improved specific mitochondrial inhibitors are under development see this as an emerging target future approaches tackling challenge infection.

Язык: Английский

Процитировано

4

New Polyene Macrolide Compounds from Mangrove-Derived Strain Streptomyces hiroshimensis GXIMD 06359: Isolation, Antifungal Activity, and Mechanism against Talaromyces marneffei DOI Creative Commons

Zhou Wang,

Jianglin Yin,

Meng Bai

и другие.

Marine Drugs, Год журнала: 2024, Номер 22(1), С. 38 - 38

Опубликована: Янв. 8, 2024

Mangrove-derived actinomycetes represent a rich source of novel bioactive natural products in drug discovery. In this study, four new polyene macrolide antibiotics antifungalmycin B-E (

Язык: Английский

Процитировано

4

Highly Reactive Group I Introns Ubiquitous in Pathogenic Fungi DOI Creative Commons
Tianshuo Liu, Anna Marie Pyle

Journal of Molecular Biology, Год журнала: 2024, Номер 436(8), С. 168513 - 168513

Опубликована: Март 5, 2024

Systemic fungal infections are a growing public health threat, and yet viable antifungal drug targets limited as fungi share similar proteome with humans. However, features of RNA metabolism the noncoding transcriptomes in distinctive. For example, harbor highly structured elements that humans lack, such self-splicing introns within key housekeeping genes mitochondria. location function these mitochondrial riboregulatory has largely eluded characterization. Here we used an RNA-structure-based bioinformatics pipeline to identify group I interrupting medically relevant fungi, revealing their fixation handful genetic hotspots ubiquitous presence across divergent phylogenies including all highest priority pathogens Candida albicans, auris, Aspergillus fumigatus Cryptococcus neoformans. We then biochemically characterized two representative from C. albicans demonstrating exceptionally efficient splicing catalysis relative previously-characterized introns. Indeed, intron displays extremely rapid catalytic turnover, even at ambient temperatures physiological magnesium ion concentrations. Our results unmask significant new set players pathogenic suggesting promising type target.

Язык: Английский

Процитировано

4

The progress and future of the treatment of Candida albicans infections based on nanotechnology DOI Creative Commons
Yang Gao,

Q. Q. Cao,

Yuyang Xiao

и другие.

Journal of Nanobiotechnology, Год журнала: 2024, Номер 22(1)

Опубликована: Сен. 16, 2024

Systemic infection with Candida albicans poses a significant risk for people weakened immune systems and carries mortality rate of up to 60%. However, current therapeutic options have several limitations, including increasing drug tolerance, notable off-target effects, severe adverse reactions. Over the past four decades, progress in developing drugs treat infections has been sluggish. This comprehensive review addresses limitations existing summarizes efforts made toward redesigning innovating or novel through nanotechnology. The discussion explores potential applications nanomedicine from perspectives: nano-preparations anti-biofilm therapy, innovative formulations "old drugs" targeting cell membrane wall, reverse resistance therapy subcellular organelles, virulence deprivation leveraging unique polymorphism albicans. These approaches are promising address above challenges enhance efficiency development infections. By harnessing nano-preparation technology transform preclinical drugs, targets will be uncovered, providing effective solutions broader horizons improve patient survival rates.

Язык: Английский

Процитировано

3

Uncovering the role of mitochondrial genome in pathogenicity and drug resistance in pathogenic fungi DOI Creative Commons
Yue Ni, Xindi Gao

Frontiers in Cellular and Infection Microbiology, Год журнала: 2025, Номер 15

Опубликована: Апрель 16, 2025

Fungal infections are becoming more prevalent globally, particularly affecting immunocompromised populations, such as people living with HIV, organ transplant recipients and those on immunomodulatory therapy. Globally, approximately 6.55 million affected by invasive fungal annually, leading to serious health consequences death. Mitochondria membrane-bound organelles found in almost all eukaryotic cells play an important role cellular metabolism energy production, including pathogenic fungi. These possess their own genome, the mitochondrial which is usually circular encodes proteins essential for production. Variation evolutionary adaptation within between species' genomes can affect function, consequently production metabolic activity, may contribute pathogenicity drug resistance certain species. This review explores link genome mechanisms of resistance, a particular focus Cryptococcus neoformans Candida albicans. insights deepen our understanding biology provide new avenues developing innovative therapeutic strategies.

Язык: Английский

Процитировано

0

An exploration of molecular signaling in drug reprocessing for Oral Squamous Cell Carcinoma DOI

Ali Nakhaei,

Sarah Marzoughi,

Sahar Ghoflchi

и другие.

European Journal of Medicinal Chemistry, Год журнала: 2025, Номер 295, С. 117816 - 117816

Опубликована: Июнь 1, 2025

Язык: Английский

Процитировано

0

Metabolic homeostasis in fungal infections from the perspective of pathogens, immune cells, and whole-body systems DOI
Harshini Weerasinghe, Helen Stölting, Adam J. Rose

и другие.

Microbiology and Molecular Biology Reviews, Год журнала: 2024, Номер 88(3)

Опубликована: Сен. 4, 2024

SUMMARY The ability to overcome metabolic stress is a major determinant of outcomes during infections. Pathogens face nutrient and oxygen deprivation in host niches their encounter with immune cells. Immune cells require adaptations for producing antimicrobial compounds mounting antifungal inflammation. Infection also triggers systemic changes organ metabolism energy expenditure that range from an enhanced produce robust response reduced as infection progresses, which coincides dysfunction. Competition nutrients between hosts pathogens means successful survival recovery balance elimination the pathogen by systems (resistance), doing so minimal damage tissues organs (tolerance). Here, we discuss our current knowledge pathogen, cell fungal infections, impact disorders, such obesity diabetes. We put forward idea that, while use regulation proliferation responses (i.e., resistance) has been growing over years, need study mechanisms control tolerance pathogens. A comprehensive understanding how resistance interventions may provide insights into therapeutic strategies could be used adjunctly drugs improve patient outcomes.

Язык: Английский

Процитировано

2

Disclosing the Antifungal Mechanisms of the Cyclam Salt H4[H2(4-CF3PhCH2)2Cyclam]Cl4 against Candida albicans and Candida krusei DOI Open Access
Inês Costa,

Inês Lopes,

Mariana Morais

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(10), С. 5209 - 5209

Опубликована: Май 10, 2024

Mycoses are one of the major causes morbidity/mortality among immunocompromised individuals. Considering importance these infections, World Health Organization (WHO) defined a priority list fungi for health in 2022 that include Candida albicans as belonging to critical group and Pichia kudriavzevii (Candida krusei) medium group. The existence few available antifungal drugs, their high toxicity, acquired fungal resistance, appearance new species with broader spectrum points out need searching antifungals, preferably multiple mechanisms action. cyclam salt H4[H2(4-CF3PhCH2)2Cyclam]Cl4 was previously tested against several revealed an interesting activity, minimal inhibitory concentration (MIC) values 8 µg/mL C. krusei 128 albicans. main objective present work deeply understand involved its activity. effects on yeast metabolic viability (resazurin reduction assay), mitochondrial function (JC-1 probe), production reactive oxygen (DCFH-DA probe) intracellular ATP levels (luciferin/luciferase assay) were evaluated. induced significant decrease activity both krusei, increase Reactive Oxygen Species (ROS) production, impaired function. latter observed by depolarization membrane levels, seems be H4[H2(4-CF3PhCH2)2Cyclam]Cl4. interference human cells CC50 value HEK-293 embryonic kidney 1.1 μg/mL HC10 red blood 0.8 μg/mL.

Язык: Английский

Процитировано

1